Timothy P. Kelly
Chief Technical OfficerMr. Timothy P. Kelly, also known as Tim, is Chief Technical Officer of ABIVAX Société Anonyme from September 21, 2026. Mr. Kelly is Member of Scientific Advisory Board of Ambulero, Inc. Mr. Kelly served as Chief Technology Officer at Caribou Biosciences, Inc. since January 2024 until 2026. He served as Chief Executive Officer of Oxford Biomedica Solutions at Oxford Biomedica plc since March 2022 until July 2023. He was Chairman at Oxford Biomedica Solutions LLC since March 10, 2022 and served as Chief Executive Officer since March 10, 2022 until July 2023. He served as Chief Operating Officer at Homology Medicines, Inc. since April 12, 2021 until March 10, 2022. He had been the Chief Technical Operations Officer of Homology Medicines, Inc. since April 2018 until April 12, 2021 and served as its Senior Vice President of Technical Operations from May 2017 to April 2018. He has technical knowledge and business operations expertise. Mr. Kelly served as a Head of Technical Operations at Sarepta Therapeutics, Inc. Prior to that. Mr. Kelly worked at Shire plc from 2009 to 2017, where he served most recently as a Senior Vice President and Head of Biologics Operating Unit from May 2016 to January 2017 and prior to that served in roles of increasing responsibility, including Interim Head of Technical Operations from August 2015 to April 2016 and Head of Product Strategy & Planning from 2014 to July 2015. Mr. Kelly also held senior positions at Biogen, Amsterdam, Netherlands, where he directed engineering & management of large scale drug substance green field capacity expansion in Denmark and managed their International multi-product supply chain operations and at UCB, Belgium, where he managed API & Biologics Technical Operations. During his service in the USAF, he flew F15’s. Mr. Kelly received his Bachelor of Science emphasis in Engineering Mechanics from the USAF Academy, emphasizing in General Engineering studies and Master of Science and Master of Business Administration from Troy University.
Positions
- Company NameABIVAX Société AnonymeStock CodeABVXPositionChief Technical OfficerColleagues
- MMMarc M. P. de GaridelCEO & Director
- SLSylvie L. GregoireIndependent Chair of the Board
- DBDidier BlondelEVP, CFO & Board Secretary
- PMPatrick MalloySenior VP & Head of Investor Relations
- IHIda HatoumChief People & Compliance Officer
- IMIan McGowanChairman of Scientific Advisory Board
- JHJune H. LeeIndependent Director
- TATroy A. IgnelziIndependent Director
